ArticleFrontiers in oncology2021

Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.

Antonio Passaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.